Genentech discovers possible prenatal clue to Alzheimer's disease

02/18/2009 | Wall Street Journal, The

Researchers at Genentech proposed that N-APP, a fragment of the amyloid precursor protein, causes the death of nerve cells and fibers in Alzheimer's patients by triggering a process that destroys the cells. This normally happens during prenatal development to get rid of excess cells, but Genentech scientists found that the process can somehow reactivate during adulthood.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations